Published in Telemedicine Law Weekly, July 21st, 2007
This trend article about Erasmus Medical Center, Rotterdam, Netherlands, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Current study results from the report, "The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease," have been published. "The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) are associated with improved outcome in patients with peripheral arterial disease. Statins may also have beneficial properties beyond their...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.